InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

InspireMD, Inc.

NSPR Clue Score57
United States Fiscal year ends December CIK 0001433607 Results filed 17 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

77
Insider
Date
Role
Action
Shares
Price
Amount
Paul Stuka
27 May 2026
Director
Buy
20,000
$0.88
$17.50K
Shane Thomas Gleason
19 May 2026
Chief Commercial Officer
Sell
22,778
$1.01
$23.01K
Paul Stuka
14 May 2026
Director
Buy
5,000
$1.15
$5.75K
Paul Stuka
13 May 2026
Director
Buy
10,000
$1.16
$11.58K
Marvin Slosman
12 May 2026
CEO and President
Buy
21,000
$1.20
$25.20K
Paul Stuka
11 May 2026
Director
Buy
10,000
$1.19
$11.90K
Paul Stuka
8 May 2026
Director
Buy
65,626
$1.16
$76.13K
Gary S Roubin
7 May 2026
Director
Buy
90,000
$1.18
$106.20K
Paul Stuka
7 May 2026
Director
Buy
6,378
$1.15
$7.33K
Scott R. Ward
7 May 2026
Director
Buy
73,255
$1.15
$84.24K
Paul Stuka
6 May 2026
Director
Buy
1,517
$1.12
$1.70K
Scott R. Ward
6 May 2026
Director
Buy
15,995
$1.15
$18.39K
Shane Thomas Gleason
2 Feb 2026
Chief Commercial Officer
Sell
2,000
$1.60
$3.21K
Shane Thomas Gleason
2 Feb 2026
Chief Commercial Officer
Sell
2,941
$1.59
$4.68K
Shane Thomas Gleason
30 Jan 2026
Chief Commercial Officer
Sell
2,900
$1.63
$4.73K
Shane Thomas Gleason
29 Jan 2026
Chief Commercial Officer
Sell
5,000
$1.65
$8.25K
Shane Thomas Gleason
28 Jan 2026
Chief Commercial Officer
Sell
12,395
$1.65
$20.46K
Shane Thomas Gleason
27 Jan 2026
Chief Commercial Officer
Sell
4,781
$1.66
$7.96K
Shane Thomas Gleason
22 Jan 2026
Chief Commercial Officer
Sell
8,411
$1.57
$13.24K
Shane Thomas Gleason
21 Jan 2026
Chief Commercial Officer
Sell
17,593
$1.62
$28.55K
Shane Thomas Gleason
20 Jan 2026
Chief Commercial Officer
Sell
2,955
$1.59
$4.71K
Shane Thomas Gleason
16 Jan 2026
Chief Commercial Officer
Sell
2,250
$1.61
$3.63K
Shane Thomas Gleason
15 Jan 2026
Chief Commercial Officer
Sell
2,909
$1.58
$4.59K
Paul Stuka
9 Dec 2025
Director
Buy
5,073
$1.81
$9.18K
Paul Stuka
5 Dec 2025
Director
Buy
5,073
$1.86
$9.44K
Paul Stuka
4 Dec 2025
Director
Buy
10,130
$1.85
$18.74K
Paul Stuka
12 Nov 2025
Director
Buy
13,431
$1.62
$21.76K
Paul Stuka
30 Jul 2025
Director
Buy indirect
20,661
$2.42
$50.00K
Marvin Slosman
30 Jul 2025
CEO and President
Buy
10,330
$2.42
$25.00K
Thomas J Kester
30 Jul 2025
Director
Buy
30,991
$2.42
$75.00K
Gary S Roubin
30 Jul 2025
Director
Buy
41,322
$2.42
$100.00K
Thomas J Kester
11 Jul 2025
Director
Exercised, kept
30,624
$1.38
$42.34K
Paul Stuka
1 Jul 2025
Director
Exercised, kept indirect
87,500
$1.38
$120.99K
Michael Berman
29 Jun 2025
Director
Exercised, kept indirect
61,248
$1.38
$84.69K
Gary S Roubin
25 Jun 2025
Director
Exercised, kept
30,624
$1.38
$42.34K
Shane Thomas Gleason
30 May 2025
Chief Commercial Officer
Sell
7,186
$2.51
$18.04K
Shane Thomas Gleason
29 May 2025
Chief Commercial Officer
Sell
3,760
$2.51
$9.44K
Shane Thomas Gleason
27 May 2025
Chief Commercial Officer
Sell
1,572
$2.51
$3.95K
Shane Thomas Gleason
23 May 2025
Chief Commercial Officer
Sell
2,482
$2.51
$6.23K
Shane Thomas Gleason
25 Feb 2025
Chief Commercial Officer
Sell
10,000
$3.65
$36.50K
Shane Thomas Gleason
4 Feb 2025
Chief Commercial Officer
Sell
5,132
$2.46
$12.62K
Shane Thomas Gleason
3 Feb 2025
Chief Commercial Officer
Sell
7,073
$2.51
$17.75K
Shane Thomas Gleason
31 Jan 2025
Chief Commercial Officer
Sell
9,923
$2.55
$25.30K
Shane Thomas Gleason
30 Jan 2025
Chief Commercial Officer
Sell
2,454
$2.51
$6.16K
Shane Thomas Gleason
29 Jan 2025
Chief Commercial Officer
Sell
3,660
$2.46
$9.00K
Shane Thomas Gleason
28 Jan 2025
Chief Commercial Officer
Sell
2,476
$2.61
$6.46K
Shane Thomas Gleason
27 Jan 2025
Chief Commercial Officer
Sell
3,858
$2.71
$10.46K
Michael Berman
24 Jun 2024
Director
Exercised, kept indirect
61,249
$1.38
$84.69K
Paul Stuka
5 Jun 2024
Director
Exercised, kept indirect
87,500
$1.38
$120.99K
Gary S Roubin
28 May 2024
Director
Exercised, kept
30,625
$1.38
$42.35K
Thomas J Kester
28 May 2024
Director
Exercised, kept
30,625
$1.38
$42.35K
Gary S Roubin
30 Nov 2023
Director
Buy
50,000
$2.53
$126.54K
Gary S Roubin
12 May 2023
Director
Buy
61,249
$1.63
$100.00K
Michael Berman
12 May 2023
Director
Buy indirect
122,497
$1.63
$200.00K
Thomas J Kester
12 May 2023
Director
Buy
61,249
$1.63
$100.00K
Paul Stuka
12 May 2023
Director
Buy indirect
175,000
$1.63
$285.72K
Gary S Roubin
18 Aug 2022
Director
Buy
35,500
$1.91
$67.77K
Gary S Roubin
28 Dec 2021
Director
Buy
16,393
$3.08
$50.44K
Paul Stuka
1 Dec 2021
Director
Buy indirect
12,037
$3.51
$42.29K
Paul Stuka
30 Nov 2021
Director
Buy indirect
18,372
$3.55
$65.22K
Paul Stuka
29 Nov 2021
Director
Buy indirect
3,177
$3.55
$11.28K
Paul Stuka
26 Nov 2021
Director
Buy indirect
1,200
$3.55
$4.26K
Paul Stuka
24 Nov 2021
Director
Buy indirect
18,328
$3.55
$65.06K
Paul Stuka
23 Nov 2021
Director
Buy indirect
1,204
$3.55
$4.27K
Paul Stuka
22 Nov 2021
Director
Buy indirect
19,188
$3.54
$67.87K
Gary S Roubin
17 Nov 2021
Director
Buy
290
$3.77
$1.09K
Gary S Roubin
17 Nov 2021
Director
Buy
25,640
$3.86
$98.87K
Gary S Roubin
25 Aug 2021
Director
Buy
22,249
$4.19
$93.25K
Gary S Roubin
8 Feb 2021
Director
Buy
241,930
$0.62
$150.00K
Michael Berman
8 Feb 2021
Director
Buy
80,640
$0.62
$50.00K
Thomas J Kester
8 Feb 2021
Director
Buy
120,960
$0.62
$75.00K
Marvin Slosman
8 Feb 2021
CEO and President
Buy
40,320
$0.62
$25.00K
Gary S Roubin
16 Oct 2020
Director
Buy
222,223
$0.45
$100.00K
Marvin Slosman
5 Jun 2020
CEO and President
Buy
55,550
$0.45
$25.00K
Thomas J Kester
3 Jun 2020
Director
Buy
50,000
$0.42
$20.75K
Paul Stuka
11 Dec 2018
Director
Sell indirect
65
$0.18
$11.54
Thomas J Kester
21 Nov 2018
Director
Sell
8
$0.21
$1.68

What was left out

Form 4 filings counted 146
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 15,200,772
Sales filed before the plan box existed 2
History held since 15 Jun 2011